Are there genetic determinants of olanzapine-induced agranulocytosis?
Gespeichert in:
Veröffentlicht in: | Pharmacopsychiatry 2000-09, Vol.33 (5), p.197 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | 197 |
container_title | Pharmacopsychiatry |
container_volume | 33 |
creator | Felber, W Naumann, R Schuler, U Fülle, M Reuster, T Garcia, K Heilemann, H |
description | |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_11071024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11071024</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-f07833629c7ad35217517b550061c3a7d1666d7aac866006312f5d3169e4dbab3</originalsourceid><addsrcrecordid>eNo1j71qwzAURjW0JGmaVyh6AYOuZEnxVEJIfyDQpZ3DtXSdqtiykeQhffoG2i7fgTMc-G7YSoA1lTK2WbK7nL-EgLoRasGWAMKCkPWKHXaJePmk654pUgmOeyqUhhAxlszHjo89xm-cQqQqRD878hzPCePcj-5Sxhzy4z277bDPtPnjmn08Hd73L9Xx7fl1vztWkxS2VJ2wW6WMbJxFr7QEq8G2WgthwCm0Howx3iK6rTFXqUB22iswDdW-xVat2cNvd5rbgfxpSmHAdDn9_1E_C9FFoQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Are there genetic determinants of olanzapine-induced agranulocytosis?</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Felber, W ; Naumann, R ; Schuler, U ; Fülle, M ; Reuster, T ; Garcia, K ; Heilemann, H</creator><creatorcontrib>Felber, W ; Naumann, R ; Schuler, U ; Fülle, M ; Reuster, T ; Garcia, K ; Heilemann, H</creatorcontrib><identifier>ISSN: 0176-3679</identifier><identifier>PMID: 11071024</identifier><language>eng</language><publisher>Germany</publisher><subject>Agranulocytosis - blood ; Agranulocytosis - chemically induced ; Agranulocytosis - genetics ; Antipsychotic Agents - adverse effects ; Benzodiazepines ; Continental Population Groups ; HLA-A2 Antigen - genetics ; Humans ; Pirenzepine - adverse effects ; Pirenzepine - analogs & derivatives</subject><ispartof>Pharmacopsychiatry, 2000-09, Vol.33 (5), p.197</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11071024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Felber, W</creatorcontrib><creatorcontrib>Naumann, R</creatorcontrib><creatorcontrib>Schuler, U</creatorcontrib><creatorcontrib>Fülle, M</creatorcontrib><creatorcontrib>Reuster, T</creatorcontrib><creatorcontrib>Garcia, K</creatorcontrib><creatorcontrib>Heilemann, H</creatorcontrib><title>Are there genetic determinants of olanzapine-induced agranulocytosis?</title><title>Pharmacopsychiatry</title><addtitle>Pharmacopsychiatry</addtitle><subject>Agranulocytosis - blood</subject><subject>Agranulocytosis - chemically induced</subject><subject>Agranulocytosis - genetics</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Benzodiazepines</subject><subject>Continental Population Groups</subject><subject>HLA-A2 Antigen - genetics</subject><subject>Humans</subject><subject>Pirenzepine - adverse effects</subject><subject>Pirenzepine - analogs & derivatives</subject><issn>0176-3679</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j71qwzAURjW0JGmaVyh6AYOuZEnxVEJIfyDQpZ3DtXSdqtiykeQhffoG2i7fgTMc-G7YSoA1lTK2WbK7nL-EgLoRasGWAMKCkPWKHXaJePmk654pUgmOeyqUhhAxlszHjo89xm-cQqQqRD878hzPCePcj-5Sxhzy4z277bDPtPnjmn08Hd73L9Xx7fl1vztWkxS2VJ2wW6WMbJxFr7QEq8G2WgthwCm0Howx3iK6rTFXqUB22iswDdW-xVat2cNvd5rbgfxpSmHAdDn9_1E_C9FFoQ</recordid><startdate>20000901</startdate><enddate>20000901</enddate><creator>Felber, W</creator><creator>Naumann, R</creator><creator>Schuler, U</creator><creator>Fülle, M</creator><creator>Reuster, T</creator><creator>Garcia, K</creator><creator>Heilemann, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20000901</creationdate><title>Are there genetic determinants of olanzapine-induced agranulocytosis?</title><author>Felber, W ; Naumann, R ; Schuler, U ; Fülle, M ; Reuster, T ; Garcia, K ; Heilemann, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-f07833629c7ad35217517b550061c3a7d1666d7aac866006312f5d3169e4dbab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Agranulocytosis - blood</topic><topic>Agranulocytosis - chemically induced</topic><topic>Agranulocytosis - genetics</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Benzodiazepines</topic><topic>Continental Population Groups</topic><topic>HLA-A2 Antigen - genetics</topic><topic>Humans</topic><topic>Pirenzepine - adverse effects</topic><topic>Pirenzepine - analogs & derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Felber, W</creatorcontrib><creatorcontrib>Naumann, R</creatorcontrib><creatorcontrib>Schuler, U</creatorcontrib><creatorcontrib>Fülle, M</creatorcontrib><creatorcontrib>Reuster, T</creatorcontrib><creatorcontrib>Garcia, K</creatorcontrib><creatorcontrib>Heilemann, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Pharmacopsychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Felber, W</au><au>Naumann, R</au><au>Schuler, U</au><au>Fülle, M</au><au>Reuster, T</au><au>Garcia, K</au><au>Heilemann, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are there genetic determinants of olanzapine-induced agranulocytosis?</atitle><jtitle>Pharmacopsychiatry</jtitle><addtitle>Pharmacopsychiatry</addtitle><date>2000-09-01</date><risdate>2000</risdate><volume>33</volume><issue>5</issue><spage>197</spage><pages>197-</pages><issn>0176-3679</issn><cop>Germany</cop><pmid>11071024</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0176-3679 |
ispartof | Pharmacopsychiatry, 2000-09, Vol.33 (5), p.197 |
issn | 0176-3679 |
language | eng |
recordid | cdi_pubmed_primary_11071024 |
source | MEDLINE; Thieme Connect Journals |
subjects | Agranulocytosis - blood Agranulocytosis - chemically induced Agranulocytosis - genetics Antipsychotic Agents - adverse effects Benzodiazepines Continental Population Groups HLA-A2 Antigen - genetics Humans Pirenzepine - adverse effects Pirenzepine - analogs & derivatives |
title | Are there genetic determinants of olanzapine-induced agranulocytosis? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20there%20genetic%20determinants%20of%20olanzapine-induced%20agranulocytosis?&rft.jtitle=Pharmacopsychiatry&rft.au=Felber,%20W&rft.date=2000-09-01&rft.volume=33&rft.issue=5&rft.spage=197&rft.pages=197-&rft.issn=0176-3679&rft_id=info:doi/&rft_dat=%3Cpubmed%3E11071024%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11071024&rfr_iscdi=true |